Fasimec Duo 50 mg/ml + 1 mg/ml Oral Suspension for Sheep

国家: 英国

语言: 英文

来源: VMD (Veterinary Medicines Directorate)

有效成分:

Ivermectin, Triclabendazole

可用日期:

Elanco Europe Ltd

ATC代码:

QP54AA51

INN（国际名称）:

Ivermectin, Triclabendazole

药物剂型:

Oral suspension

处方类型:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

治疗组:

Sheep

治疗领域:

Anthelmintic flukicide

授权状态:

Authorized

授权日期:

2007-11-20

产品特点

Revised: December 2020
AN: 01398/2020
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE VETERINARY MEDICINAL PRODUCT
Fasimec Duo 50 mg/ml + 1 mg/ml oral suspension for sheep.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENTS:
Ivermectin
1
mg/ml
Triclabendazole
50
mg/ml
EXCIPIENTS:
Methyl parahydroxybenzoate (E218)
1.4
mg/ml
Propyl parahydroxybenzoate (E216)
0.5
mg/ml
Benzyl alcohol
5.0
mg/ml
For the full list of excipients, see section
6.1.
3. PHARMACEUTICAL FORM
Oral suspension
Cream coloured aqueous oral suspension
.
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
For sheep over 3 months of age.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed trematode (fluke) and nematode or arthropod
infections due to
gastrointestinal roundworms, lungworms, liver fluke and nasal bots.
GASTROINTESTINAL NEMATODES (ADULT AND IMMATURE):
_Haemonchus contortus, Teladorsagia (Ostertagia) circumcincta,
Trichostrongylus _
_spp, Cooperia spp, Nematodirus spp _including _N. battus_,
_Strongyloides papillosus, _
_Oesophagostomum spp_, and adult _Chabertia ovina._
Inhibited larval stages and benzimidazole resistant strains of
_Haemonchus contortus_
and _Teladorsagia (Ostertagia) circumcincta _are also controlled.
LIVER FLUKE (MATURE, IMMATURE AND EARLY IMMATURE STAGES DOWN TO LESS
THAN 1
WEEK OF AGE):
_ Fasciola hepatica_
Revised: December 2020
AN: 01398/2020
Page 2 of 7
LUNGWORMS (ADULT AND IMMATURE):
_Dictyocaulus filaria _
NASAL BOTS (ALL
STAGES): _Oestrus ovis_
4.3
CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredients or any of
the excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
I.
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:
·Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
·
Underdosing which m